These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry. Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW Perit Dial Int; 2018; 38(4):257-265. PubMed ID: 29437143 [TBL] [Abstract][Full Text] [Related]
7. Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time. Chao CT; Lee SY; Yang WS; Chen HW; Fang CC; Yen CJ; Chiang CK; Hung KY; Huang JW PLoS One; 2014; 9(10):e110315. PubMed ID: 25314341 [TBL] [Abstract][Full Text] [Related]
8. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Early-Onset Peritonitis in Southern Chinese Peritoneal Dialysis Patients. Wu H; Huang R; Yi C; Wu J; Guo Q; Zhou Q; Yu X; Yang X Perit Dial Int; 2016 11-12; 36(6):640-646. PubMed ID: 27147289 [TBL] [Abstract][Full Text] [Related]
10. Exit site infection and peritonitis due to Serratia species in patients receiving peritoneal dialysis: Epidemiology and clinical outcomes. Au CWH; Yap DYH; Chan JFW; Yip TPS; Chan TM Nephrology (Carlton); 2021 Mar; 26(3):255-261. PubMed ID: 33150699 [TBL] [Abstract][Full Text] [Related]
11. Early Peritonitis in a Large Peritoneal Dialysis Provider System in Colombia. Vargas E; Blake PG; Sanabria M; Bunch A; López P; Vesga J; Buitrago A; Astudillo K; Devia M; Sánchez R Perit Dial Int; 2017 1-2; 37(1):30-34. PubMed ID: 27605683 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal Dialysis-Related Peritonitis With Acinetobacter Ursingii. Atas DB; Velioglu A; Asicioglu E; Tigen E Ther Apher Dial; 2016 Apr; 20(2):205-6. PubMed ID: 26916675 [No Abstract] [Full Text] [Related]
13. Streptococcus bovis peritonitis complicating peritoneal dialysis--a review of 10 years' experience. Yap DY; To KK; Yip TP; Lui SL; Chan TM; Lai KN; Lo WK Perit Dial Int; 2012; 32(1):55-9. PubMed ID: 21804137 [TBL] [Abstract][Full Text] [Related]
14. Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. Gaur A; Garg A; Prakash P; Anupurba S; Mohapatra TM J Health Popul Nutr; 2008 Jun; 26(2):183-8. PubMed ID: 18686551 [TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan. Lin WH; Tseng CC; Wu AB; Chang YT; Kuo TH; Chao JY; Wang MC; Wu JJ Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1699-1707. PubMed ID: 29931659 [TBL] [Abstract][Full Text] [Related]
16. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial. Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796 [TBL] [Abstract][Full Text] [Related]
17. Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection. Vitkauskiene A; Dambrauskiene A; Cerniauskiene K; Rimdeika R; Sakalauskas R Scand J Infect Dis; 2013 Mar; 45(3):213-8. PubMed ID: 23113773 [TBL] [Abstract][Full Text] [Related]
18. Are ISPD Guidelines on Peritonitis Diagnosis Too Narrow? A 15-Year Retrospective Single-Center Cohort Study on PD-Associated Peritonitis Accounting for Untrained Patients. Balzer MS; Claus R; Haller H; Hiss M Perit Dial Int; 2019; 39(3):220-228. PubMed ID: 30846609 [No Abstract] [Full Text] [Related]
19. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
20. Improved Outcome of Enteric Peritonitis in Peritoneal Dialysis Patients Aged 50 Years and Older with Temporary Discontinuation of Peritoneal Dialysis and Intravenous Meropenem. Abrahams AC; Rüger W; Ter Wee PM; van Ittersum FJ; Boer WH Perit Dial Int; 2017; 37(3):298-306. PubMed ID: 28096441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]